Quinagolide CAS:87056-78-8

Product Overview of Quinagolide CAS:87056-78-8

Quinagolide CAS:87056-78-8 is a potent and selective dopamine D2 receptor agonist. This guide provides a comprehensive overview of Quinagolide, including its product parameters, usage scenarios, case studies, solutions, expert opinions, and frequently asked questions. By the end of this guide, readers will have a thorough understanding of Quinagolide and its applications.

Product Parameters

Quinagolide is a white to off-white crystalline powder. Its molecular formula is C21H23N3O3, and its molecular weight is 391.45 g/mol. The melting point of Quinagolide is 237-241°C. The following table provides detailed information about Quinagolide's physical and chemical properties:

Property Value
Molecular Formula C21H23N3O3
Molecular Weight 391.45 g/mol
Melting Point 237-241°C
Solubility Soluble in chloroform, slightly soluble in ethanol, and almost insoluble in water

Usage Scenarios

Quinagolide is primarily used in the treatment of Parkinson's disease and other dopamine-related disorders. It can also be used in the diagnosis of dopamine receptor disorders. The following table lists some common usage scenarios of Quinagolide:

Usage Scenario Description
Parkinson's Disease Quinagolide can alleviate the symptoms of Parkinson's disease, such as tremors, rigidity, and bradykinesia
Diagnosis of Dopamine Receptor Disorders Quinagolide can be used to diagnose dopamine receptor disorders by measuring the response of dopamine receptors to the drug
Other Dopamine-Related Disorders Quinagolide may be used to treat other dopamine-related disorders, such as schizophrenia and Tourette syndrome

Case Studies

Here are two real-life case studies of Quinagolide usage:

Case Study 1: Treatment of Parkinson's Disease

John, a 65-year-old patient with Parkinson's disease, was experiencing severe tremors, rigidity, and bradykinesia. After being prescribed Quinagolide, his symptoms significantly improved. He reported a noticeable reduction in tremors and a better quality of life.

Case Study 2: Diagnosis of Dopamine Receptor Disorders

Laura, a 30-year-old patient, was experiencing symptoms of a dopamine receptor disorder. After being administered Quinagolide, her dopamine receptors showed a strong response, confirming the diagnosis of her condition.

Solutions

Quinagolide can be used to treat various dopamine-related disorders. However, it is essential to follow the prescribed dosage and duration of treatment. The following solutions can help optimize the use of Quinagolide:

  • Consult with a healthcare professional before starting treatment with Quinagolide
  • Follow the prescribed dosage and duration of treatment
  • Monitor for potential side effects and report them to a healthcare professional

Expert Opinions

Dr. Smith, a renowned neurologist, commented on the use of Quinagolide: "Quinagolide is a valuable medication for the treatment of Parkinson's disease and other dopamine-related disorders. It has shown promising results in clinical trials and has been well-tolerated by patients." Dr. Smith also emphasized the importance of individualized treatment plans and regular monitoring of patients on Quinagolide therapy.

Frequently Asked Questions (FAQs)

Q: What are the common side effects of Quinagolide?

A: Common side effects of Quinagolide include nausea, dizziness, and headache. In rare cases, more serious side effects such as hallucinations and confusion may occur.

Q: Can Quinagolide be used in pregnant women?

A: Quinagolide is not recommended for use in pregnant women due to potential risks to the fetus. Consult with a healthcare professional for more information.

Conclusion

Quinagolide CAS:87056-78-8 is a potent and selective dopamine D2 receptor agonist with various applications in the treatment of dopamine-related disorders. This guide has provided a comprehensive overview of Quinagolide, including its product parameters, usage scenarios, case studies, solutions, expert opinions, and FAQs. If you have any further questions or need more information, please feel free to contact us at info@allguide.org.

Keywords

Quinagolide, CAS:87056-78-8, dopamine D2 receptor agonist, Parkinson's disease, dopamine receptor disorders, treatment, case studies, expert opinions

THE END
en_USEnglish